IP Library Granted Patent US 9,029,114
Granted Patent B2
US 9,029,114 · App. 14/055,966 · Granted May 12, 2015

Type II restriction-modification system methylation subunit of

Inventors: Brady D. Lee (West Richland, WA); Deborah T. Newby (Idaho Falls, ID); Jeffrey A. Lacey (Idaho Falls, ID); David N. Thompson (Idaho Falls, ID); Vicki S. Thompson (Idaho Falls, ID); William A. Apel (Jackson, WY); Francisco F. Roberto (Highlands Ranch, CO); David W. Reed (Idaho Falls, ID)
Assignee: Battelle Energy Alliance, LLC
C12N15/87C12N9/00C12N9/52C12N9/1007
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,029,114
App. No.
14/055,966
Granted
May 12, 2015
Kind
B2
Abstract

Isolated and/or purified polypeptides and nucleic acid sequences encoding polypeptides from Alicyclobacillus acidocaldarius are provided. Further provided are methods for modulating or altering recombination inside or outside of a cell using isolated and/or purified polypeptides and/or nucleic acid sequences from Alicyclobacillus acidocaldarius.

Claims (8)

1. A method of modulating or altering recombination, the method comprising:

providing an isolated or purified polypeptide having at least 90% sequence identity to SEQ ID No. 2976 to a nucleotide sequence in which a genetic recombination event is desired.

2. The method according to claim 1 , wherein the polypeptide has activity at or below about pH 8.

3. The method according to claim 1 , wherein the polypeptide has activity at a temperature at or above about 50 degrees Celsius.

4. The method according to claim 1 , wherein the modulation or alteration of recombination occurs at or below about pH 8.

5. The method according to claim 1 , wherein the modulation or alteration of recombination occurs at a temperature at or above about 50 degrees Celsius.

6. The method according to claim 1 , wherein the purified or isolated polypeptide is glycosylated, pegylated, or otherwise post-translationally modified.

7. The method according to claim 1 , wherein the polypeptide has as a Type II restriction-modification system methylation subunit.

Assignments (1)
CONFIRMATORY LICENSE Recorded Jun 3, 2014
From: BATTELLE ENERGY ALLIANCE, LLC
To: ENERGY, UNITED STATES DEPARTMENT OF
Reel/Frame 033114/0786 →
Continuity (3)
Division 13604979 · Sep 6, 2012
Division 12800045 · May 5, 2010
Related Publication 20140093936A1 · Apr 3, 2014